Reference number : 276-2007-2008-Q2-00070, amendment number : , agreement type : C, recipient legal name : Newlab Clinical Research Inc.|Newlab Clinical Research Inc., recipient country : CA, recipient province : NL, recipient city : St. John's|St. John's, recipient postal code : A1B 4S8, program name english : Atlantic Innovation Fund (AIF) - II, program name french : Fonds d'innovation de l'Atlantique (FIA) - II, program purpose english : nan, program purpose french : nan, agreement title english : 190622, agreement title french : 190622, agreement number : 190622, agreement value : 2247621.0, agreement start date : 2007-07-27, agreement end date : 2012-03-31, description english : Rational drug design for psoriasis, description french : Élaboration rationnelle de médicaments pour psoriasis, expected results english : nan, expected results french : nan, additional information english : The assistance type is Conditionally Repayable Contribution. The total government funding is $3,527,097.00., additional information french : Le type d'aide est Contribution à remboursement conditionnel. Le financement gouvernemental total est 3 527 097,00 $., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique